linezolid oral / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   24 Trials   24 Trials   646 News 
41 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linezolid oral / Generic mfg.
2011-000158-47: Assessment of extracellular concentrations of linezolid and other currently approved antibiotics in patients presenting with severe bacterial lung infection Messung extrazellulärer Konzentrationen von Linezolid und anderer zugelassener Antibiotika bei Patienten mit schwerer bakterieller Entzündung der Lunge.

Ongoing
4
40
Europe
Solution for infusion, Zyvoxid™ 600 mg in ready-to-use infusion bags [300 ml]
Klin. Abtlg. für Thorax- & Hyperbare Chirurgi
Subjects who are scheduled to undergo elective open-chest lung surgery will be includedin the study.
 
 
2012-002774-31: Pre-emptive targeted and optimized treatment of critical airway colonization to prevent Ventilator Associated Pneumonia: a randomized controlled study Trattamento precoce mirato e ottimizzato della colonizzazione critica delle vie aeree per prevenire la Polmonite associata a ventilazione meccanica: studio randomizzato controllato

Ongoing
4
300
Europe
Powder for solution for infusion, Solution for infusion, Powder and solvent for solution for infusion, ZYVOXID*1SACCA INF 2MG/ML, PIPERACILLINA DOROM*FL 1G+F2ML, PENSTAPHO*IM IV 1FL+F 1G, MERREM*EV POLV 10FL 1000MG, UNASYN*EV 1FL 1G+2G, COLIMICINA*IM FL 1000000U4ML+F, GLAZIDIM VENA 1*1FL 1G+1F 10ML
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI, AIFA (bandi per la ricerca indipendente)
Ventilator Associated Pneumonia Polmonite da ventilazione meccanica, Ventilator Associated Pneumonia Polmonite da ventilazione meccanica, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2008-006153-41: Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection

Ongoing
4
10
Europe
Zyvoxid™ 600 mg in ready-to-use infusion bags [300 ml], Zyvoxid™ 600 mg in ready-to-use infusion bags [300 ml]
Medical university Graz, Department of Plastic Surgery
The study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. Patients must be subjected to undergo surgical debridement and intravenous antimicrobial therapy.
 
 
2010-023683-41: Pk/Pd aspects of linezolid in critically ill patients with late onset Ventilator-Associated Pneumonia. Intermittent versus Continuous Infusion Introduction

Ongoing
4
40
Europe
ZYVOXID, ZYVOXID
POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
ventilator associated pneumoniae
 
 
2013-000899-16: Investigation of the blood levels of selected antibiotics in critically ill patients undergoing dialysis

Ongoing
4
40
Europe
Zyvoxid 600 mg, Meropenem Eberth 1g, Zyvoxid 600 mg (Pfizer), Meropenem Eberth 1g, Zyvoxid 600 mg (Pfizer), Meropenem Eberth 1g
Department of Pharmacy Unversitätsmedizin Mainz, Department of Pharmacy Universitätsmedizin Mainz
Sepsis and acute renal failure (ARF) are pathological entities that commonly co-exist in patients admitted to intensive care. Antibiotic dosing in septic patients with ARF can be complicated and may result in either underdosing, causing treatment failure and antibiotic resistance, or overdosing resulting in drug toxicity. The aim of this study is to collect pharmacokinetic data for evaluating underdosing or overdosing of linezolid and meropenem in patients receiving renal replacement therapy.
 
 
2014-001276-56: Multicentre, randomised controlled clinical trial to compare minocycline plus rifampicin with linezolid against MRSA in complex skin and skin structure infections (cSSSI).

Ongoing
4
100
Europe
Rifampicin, minocycline, Zyvoxid 600mg, Rifampicin, minocycline, Zyvoxid, Zyvoxid
European Commission, Hellenic Institute for the Study of Sepsis, European Commisssion, Hellenic Institute for the Study of Sepsis
Complicated Skin and Skin Structure infections caused by Methicillin Resistant Staphylococcus Aureus
 
 
2019-002845-39: Oral antibiotics for treatment of brain abscess

Not yet recruiting
4
400
Europe
Meropenem, Concentrate for solution for injection/infusion, Concentrate and solvent for solution for injection/infusion, Tablet, Rocephalin, Cefotaxime, Metronidazole, Amoxicillin, Moxifloxacin, Linezolid, Clindamycin, Merrem (meropenem)
Aalborg University Hospital, Aalborg University Hospital
Brain abscess, Brain infection consisting of encapsulated bacteria, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2020-003444-80: Test of antibiotic resistance of bacteria in biofilm for the treatment of prosthetic infections; a prospective randomized study Test för bestämning av antibiotikaresistens i biofilm vid behandling av ledprotesinfektion; en prospektiv randomiserad studie

Not yet recruiting
4
64
Europe
Capsule, Tablet, Capsule, hard, Film-coated tablet, Rimactan, Fucidin, Dalacin, Tavanic, Zyvoxid, Bactrim forte
Sahlgrenska University Hospital, Västra Götalandsregionen, Centre for Antibiotic Resistance Research (CARe)
Periprosthetic hip or knee joint infections, Infections in hip or knee joint with a hip or knee replacement implant, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2020-001024-34: Oral antimicrobial treatment vs. outpatient parenteral for infectiveendocarditis. Tratamiento antimicrobiano oral vs. parenteral ambulatorio para la endocarditis infecciosa

Not yet recruiting
4
360
Europe
amoxicillin, cefaclor, ciprofloxacin, clindamycin, Dicloxacillin, Fusidic acid, Fusidic Acid, Levofloxacin, levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Sulfamethoxazole/trimethoprim, sulfamethoxazole /trimethoprin, Tedizolid, cefaclor, Dicloxacillin, Dicloxaxillin ev, Rifampicina, septrin, 49708-146-01, 856866-72-3, Tablet, Injection, Solution for injection, Solution for infusion, Capsule, Concentrate for solution for injection/infusion, , Film-coated tablet, Coated tablet, Solution for solution for infusion, Concentrate for solution for infusion, Concentrate and solvent for solution for infusion, Concentrate and solvent for concentrate for solution for infusion, Amoxicillin, ciprofloxacin
Fundació Clínic per a la Recerca Biomèdica, Instituto de Salud Carlos III
infective endocarditis endocarditis infecciosa, infective endocarditis endocarditis infecciosa, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2021-003891-15: Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ensayo clínico para evaluar la seguridad y eficacia de un tratamiento de 7 días frente a 14 días para infecciones por enterococos.

Not yet recruiting
4
284
Europe
Ciprofloxacin, ampicilin, vancomycin, linezolid, daptomycin, amoxicillin / clavulanic acid, piperacillin / tazobactam, amoxicilin, Film-coated tablet + pessary, Suspension for injection, Powder and solvent for solution for infusion, Solution for injection/infusion, Powder and solvent for solution for injection/infusion, Film-coated tablet, Tablet, Ciprofloxacin, ampicilin, vancomycin, linezolid, daptomycin, amoxicillin / clavulanic acid, piperacillin / tazobactam, amoxicilin
Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI), Instituto de Salud Carlos III. Ministerio de Ciencia e Innovación
Adult patients with uncomplicated bacteremia caused by E. faecalis or E. faecium. Pacientes adultos con bacteriemias no complicadas causadas por E. Faecalis o E. faecium., Adult patients with infections that produce the passing of certainbacteria to the bloodstream. Pacientes adultos con infecciones que producen el paso de ciertasbacterias al torrente sanguíneo., Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2021-004108-16: Markers that indicate the drug concentration in the infection place in very ill patients

Not yet recruiting
4
60
Europe
Daptomycin, Powder for solution for injection/infusion, Powder for solution for infusion, Solution for infusion, Powder for concentrate for solution for injection/infusion, Meropenem, Piperacillin/Tazobactam, ZYVOXID, Daptomycin
Medical University Vienna, Medical University of Vienna - Department of Clinical PHarmacology
All patients given standard of care intravenous therapy of the studied antibiotics will be screened against the inclusion criteria. Two groups are included: Group A (septic patients with organ dysfunction defined as SOFA >2) and Group B (control group of non-septic patients without organ dysfunction defined as SOFA <2)., Patients who receive the studied drugs., Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2020-005772-35: Etude sur l'usage et les effets secondaires du linezolid en pratique clinique: Suivi de patients traités dans des hôpitaux belges

Not yet recruiting
4
120
Europe
Linezolid, Coated tablet, Solution for injection, Zyvoxid
UCLouvain, Louvain Drug Research Institute
All infections treated with the antibiotic linezolid, All infections treated with the antibiotic linezolid, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
ChiCTR2100053968: Early bactericidal activity, safety and tolerance of Contezolid tablets in patients of newly diagnosed sensitive pulmonary tuberculosis and multidrug-resistant pulmonary tuberculosis

Not yet recruiting
4
50
 
sensitive group: Contezolid tablets or Linezolid tablets ;multidrug-resistant group: Contezolid tablets or Linezolid tablets
Shanghai Pulmonary Hospital; Shanghai Pulmonary Hospital, Shanghai MicuRx Pharmaceutical Company
pulmonary tuberculosis
 
 
2015-002987-17: Continuous administration of linezolid: improving the dosage of an antibiotic Administración continua de linezolid: mejorando la forma de dosificación de un antibiótico

Ongoing
3
25
Europe
Solution for infusion, Zyvoxid
Helena Barrasa, Helena Barrasa
Infection Infecciones causadas por microorganismos gran positivos multirresistentes, Infection in the intensive care unit Infecciones en las unidades de cuidados intensivos, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
ZeNix, NCT03086486: Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Completed
3
181
RoW
Pretomanid, PA-824, Pa, Linezolid, L, Lin, Zyvox, Bedaquiline, TMC-207, B, Sirturo, Placebo Linezolid
Global Alliance for TB Drug Development
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR, Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pre-XDR-TB, XDR-TB
02/21
02/22
2021-003914-38: Different antimicrobial durations for the treatment of infections associated with OsteosynthesisMaterial implanted after long bone fractures DIFERENTES DURACIONES DE TRATAMIENTO ANTIMICROBIANO DE INFECCIONES ASOCIADAS AL MATERIAL DE OSTEOSÍNTESIS TRAS FRACTURA DE HUESO LARGO

Not yet recruiting
3
378
Europe
Ampicillim, amoxicillin/clavulanic, Cefazolin, Cefepime, Ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin, Powder and solvent for solution for infusion, Powder and solvent for solution for injection, Powder for solution for injection, Powder and solvent for suspension for injection, Powder for solution for injection/infusion, Tablet, , Capsule, Ampicillim, Amoxicillin/Clavulanic, Cefazolin, Cefepime, ceftazidime, CEFTRIAXONE, cloxacillin, daptomycin, Meropenem, Teicoplanin, Vancomycin, Amoxicillin, Amoxicillin / clavulanic acid, Ciprofloxacin, Clindamycin, Sulfametoxazol trimetoprim, Levofloxacin, Linezolid, Moxifloxacin, Rifampicin
Fundación Pública Andaluza para la Gestión de la Investigación, Instituto de Salud Carlos III. Ministerio de Ciencia e
Patients with long bone fractures who have had osteosynthesis material implanted to stabilize and assist fracturehealing and meet the criteria for Infections associated with osteosynthesis material Pacientes con fracturas de huesos largos a quienes se les ha implantado material de osteosíntesis para estabilizar y ayudar a la curación de la fractura y que cumplen con los criterios de Infecciones asociadas con el material de osteosíntesis., Patients with infections due to the implant used to stabilize a long bone fracture Pacientes con infecciones debidas al implante usado para estabilizar una fractura de hueso largo, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2022-004192-16: Study to evaluate the efficacy of autovaccines versus antibiotic treatment in hip or knee prosthesis infections. Estudio para evaluar la eficacia de las autovacunas frente a tratamiento antibiótico en infecciones de protésis de cadera o rodilla.

Not yet recruiting
3
20
Europe
AUTOVACCUNA, amoxycillin, cotrimoxazole, doxycycline, metronidazole, ciprofloxacin, amoxicillin-clavulanic acid, linezolid, fluconazole, clindamycin, Sublingual spray, emulsion, Capsule, Tablet, AUTOVACUNA 300 FTU/mL, suspension for sublingual spraying, amoxycillin, cotrimoxazole, doxycycline, metronidazole, ciprofloxacin, amoxicillin-clavulanic acid, linezolid, fluconazole, clindamycin
idival, IDIVAL
Patients with chronic infections of hip and knee prostheses, without the possibility of curative treatment of the infection. Pacientes con infecciones crónicas de prótesis de cadera y rodilla, sin posibilidad de tratamiento curativo de la infección., Patients with hip or knee prosthesis infections. Pacientes con infecciones de prótesis de cadera o rodilla, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
NCT04062201: Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

Completed
3
402
RoW
Bedaquiline Oral Tablet, Sirturo, Linezolid Oral Tablet, Zyvox, Delamanid in Oral Dosage Form, Deltyba, Clofazimine Oral Product, Lamprene, Levofloxacin Oral Tablet, Isoniazid Oral Product, INH, Ethambutol Oral Product, Pyrazinamide Oral Product
Wits Health Consortium (Pty) Ltd, Regents of the University of California, University of Cape Town, Perinatal HIV Research Unit of the University of the Witswatersrand
Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis, Multi Drug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis
04/24
04/24
Trep-AByaws, NCT05764876: Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome

Completed
3
465
RoW
Linezolid Oral Tablet, Zyvox, Zyvoxid, Azithromycin Oral Tablet, Zithromax
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, National Department of Health, Papua New Guinea, School of Medicine and Health Sciences, University of Papua New Guinea
Yaws, Cutaneous Ulcer
06/24
12/24
EVOS, NCT06336824: Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia

Recruiting
3
290
RoW
Tab. Trimethoprim-sulfamethoxazole, Tab. Clindamycin, Tab. Cephalexin, or Tab. Linezolid, Bactrim, Dalacin, Ospexin, Zyvox, IV Cloxacillin, IV Cefazolin, IV Vancomycin, or IV Ceftaroline, Cloxacillin Sodium, Cefazolin Sandoz, Vancotex, Zinforo
Clinical Research Centre, Malaysia
Staphylococcus Aureus Bacteremia
05/25
06/25
endTB-Q, NCT03896685: Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance

Completed
3
323
RoW
Bedaquiline 100 MG, TMC207, Delamanid 50 MG Oral Tablet, Clofazimine 100 MG Oral Capsule, Linezolid 600Mg Tab, Control arm MDR-TB regimen, designed according to latest WHO guidelines
Médecins Sans Frontières, France, Partners in Health, Harvard Medical School (HMS and HSDM), Epicentre, Institute of Tropical Medicine, Belgium, Socios En Salud, Peru, Interactive Research and Development, University of San Francisco
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses, Mycobacterial Infections, Bacterial Infections, Gram-Positive Bacterial Infections
10/24
12/24
PRISM-TB, NCT06441006: Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis

Not yet recruiting
3
690
RoW
Bedaquiline, Sirturo, Linezolid, Zyvox, Pretomanid, Pretamyl, Moxifloxacin, Avelox, Control Arm FQ-S MDR/RR-TB regimen, designed according to latest WHO guidelines
University of California, San Francisco, Johns Hopkins University
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR
12/30
06/31
PRACTECAL-EE, NCT04207112: Economic Evaluation of New MDR TB Regimens

Completed
2/3
73
RoW
Bedaquiline, Sirturo, R207910, TMC207, Pretomanid, PA-824, Moxifloxacin, Avelox, BAY 12-8039, Linezolid, Zyvox, Clofazimine, Lamprene, Standard Drugs
Medecins Sans Frontieres, Netherlands, London School of Hygiene and Tropical Medicine, Ministry of Health, Republic of Uzbekistan, Ministry of Public Health, Republic of Belarus, THINK TB & HIV Investigative Network, University of Liverpool, Wits Health Consortium (Pty) Ltd
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculoses
08/22
08/22
TB-PRACTECAL, NCT02589782: Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Completed
2/3
552
RoW
Bedaquiline, Sirturo, R207910, TMC207, Pretomanid, PA-824, Moxifloxacin, Avelox, Linezolid, Zyvox, Clofazimine, Lamprene, Locally accepted standard of care which is consistent with the WHO recommendations for the treatment of M/XDR-TB.
Medecins Sans Frontieres, Netherlands, London School of Hygiene and Tropical Medicine, Global Alliance for TB Drug Development, University College, London, Drugs for Neglected Diseases, Swiss Tropical & Public Health Institute, eResearch Technology, Inc., Ministry of Health, Republic of Uzbekistan, World Health Organization, Ministry of Public Health, Republic of Belarus, THINK TB & HIV Investigative Network, University of Liverpool, Wits Health Consortium (Pty) Ltd, Rutgers, The State University of New Jersey, University of California, San Francisco
Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary
08/22
08/22

Active, not recruiting
2/3
240
RoW
Bedaquiline, Sirturo, R207910, TMC207, Pretomanid, PA-824, Moxifloxacin, Avelox, BAY 12-8039, Linezolid, Zyvox, Clofazimine, Lamprene
Medecins Sans Frontieres, Netherlands, London School of Hygiene and Tropical Medicine, Global Alliance for TB Drug Development, University College, London, Drugs for Neglected Diseases, Swiss Tropical & Public Health Institute, eResearch Technology, Inc., Ministry of Health, Republic of Uzbekistan, World Health Organization, Ministry of Public Health, Republic of Belarus, THINK TB & HIV Investigative Network, University of Liverpool, Wits Health Consortium (Pty) Ltd, Hackensack Meridian Health, University of California, San Francisco, Minsk Republican Research and Practical Centre for Pulmonology and Tuberculosis
Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis, Pulmonary Tuberculosis
09/22
09/22
PRACTECAL-PRO, NCT03942354: Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Completed
2/3
137
RoW
Bedaquiline, Sirturo, R207910, TMC207, Pretomanid, PA-824, Moxifloxacin, Avelox, BAY 12-8039, Linezolid, Zyvox, Clofazimine, Lamprene, Directly observed therapy (DOT)
Medecins Sans Frontieres, Netherlands, University of Sussex, London School of Hygiene and Tropical Medicine, THINK TB & HIV Investigative Network, Wits Health Consortium (Pty) Ltd, Ministry of Public Health, Republic of Belarus, Ministry of Health, Republic of Uzbekistan
Multidrug Resistant Tuberculosis
05/22
05/22
2011-005526-22: Concentration of cefazolin and linezolid in sternal tissue in coronary artery bypass grafting

Ongoing
2
10
Europe
CEFAZOLIN "Sandoz" 2g - Trockenstechampulle, Zyvoxid 2 mg/ml-Infusionslösung, 1–24227, Infusion, CEFAZOLIN "Sandoz" 2g - Trockenstechampulle, Zyvoxid 2 mg/ml-Infusionslösung
Medizinische Universität Wien, Medical University of Vienna
perioperative antibiotic prophylaxis during coronary artery bypass grafting, perioperative antibiotic prophylaxis during heart surgery, Diseases [C] - Bacterial Infections and Mycoses [C01]
 
 
2020-000050-10: Finding the best treatment for lung disease from infection with Mycobacterium abscessus.

Not yet recruiting
2
300
Europe
Amikacin, Tigecycline, Imipenem and Cilastatin, Cefoxitin, Azithromycin, Clofazimine, Ethambutol, Clarithromycin, Linezolid, Trimethoprim and Sulfamethoxazole, Doxycycline, Moxifloxacin, Bedaquiline, Rifabutin, Solution for injection, Powder for solution for infusion, Film-coated tablet, Powder for oral suspension, Capsule, Tablet, Capsule, hard, Clofazimine "Lamprene", Trimethoprim and Sulfamethoxazole "SAD"
University of Queensland, Medical Research Futures Fund, Cystic Fibrosis Foundation, Anonymous Donor, Thoracic Society of Australia and New Zealand, The University of Queensland, Children's Hospital Foundation
Mycobacterium abscessus pulmonary disease, Nontuberculous mycobacterium (NTM) are a group of bacteria. These bacteria can cause significant lung damage in both healthy people and those with underlying lung disease., Diseases [C] - Respiratory Tract Diseases [C08]
 
 
NCT04983901: PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN

Completed
2
100
US
Imipenem/Cilastatin/Relebactam, RECARBRIO™, Cefepime, Meropenem, Meropenem Trihydrate, Merrem I.V., SM-7338, Piperacillin-Tazobactam, PIPER/TAZO, Piperacillin/Tazobactam, Zosyn, Vancomycin, Daptomycin, Cubicin, LY146032, Linezolid, Zyvox
M.D. Anderson Cancer Center, Merck Sharp & Dohme LLC
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
10/23
10/23
NCT06058299: Phase 2 Trial Assessing TBAJ876 or Bedaquiline, with Pretomanid and Linezolid in Adults with Drug-sensitive Pulmonary Tuberculosis

Active, not recruiting
2
309
RoW
TBAJ-876, Pretomanid, PA-824, Dovprela, Linezolid, Zyvox, Bedaquiline, Sirturo, TMC207, HRZE, HR
Global Alliance for TB Drug Development
Pulmonary TB, Pulmonary Tuberculosis, Drug Sensitive Tuberculosis
12/24
06/26
NCT05548426: Linezolid for Syphilis Pilot Study

Recruiting
2
24
US
Group B, Linezolid 10d, zyvox, Group A, Penicillin, bicillin
University of Southern California, Universidad Peruana Cayetano Heredia, The University of Texas Health Science Center, Houston
Syphilis
12/25
03/26
TEDITUB, NCT05534750: Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis

Recruiting
2
60
Europe
Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard quadruple therapy arm
Assistance Publique - Hôpitaux de Paris
Tuberculosis, Multidrug Resistant Tuberculosis
04/26
05/26
DRAMATIC, NCT03828201: Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TB

Recruiting
2
220
RoW
Delamanid, Deltyba, Levofloxacin, Levaquin, Bedaquiline, Sirturo, Clofazimine, Lamprene, Linezolid, Zyvox
Boston University, Novartis Pharmaceuticals, Pfizer, Otsuka Pharmaceutical Co., Ltd., University of California, San Francisco, Westat, National Institute of Allergy and Infectious Diseases (NIAID), University of Colorado, Denver, Harvard Medical School (HMS and HSDM), National Lung Hospital, Vietnam, De La Salle Health Sciences Institute, Philippines
Tuberculosis, Multidrug-Resistant
05/27
05/27
ChiCTR-IIR-16009250: An open label, randomized, single-dose, two-period, two-sequence, crossover pivotal study to assess the Linezolid tablet bioequivalence of in healthy adult subjects under fasting/ Fed condition

Recruiting
1
48
 
The first cycle on an empty stomach with test product; The second cycle taken on an empty stomach reference preparations; ;The first cycle on an empty stomach with reference product; The second cycle taken on an empty stomach test product ;The first cycle on an fed condation with test product; The second cycle taken on fed condation reference preparations; ;The first cycle on an fed condation with reference product; The second cycle taken on an empty stomach test product;
The First Hospital of Jilin University; Jiangsu Hansoh Pharmaceutical Group, Jiangsu Hansoh Pharmaceutical Group
NA
 
 
2018-002813-37: Pharmacokinetics of different antibiotics in cerebrospinal fluid in children with malignant brain tumors – a pilot study Pharmakokinetik verschiedener Antibiotika im Liquor von Kindern mit malignen Hirntumoren - eine Pilotstudie

Ongoing
1
40
Europe
Augmentin, Ceftriaxon, Ciprofloxacin, Ciproxin, Fosfomycin, Gentamicin, Linezolid, Meropenem, Cefuroxim, Vancomycin, Eusaprim, Coated tablet, Powder for injection, Powder for infusion, Infusion, Tablet, Augmentin, Cefotaxim Eberth, Ceftriaxon, Ciprofloxacin, Ciproxin, Fosfomycin, Gentamicin, Linezolid, Meropenem, Cefuroxim, Vancomycin, Eusaprim
Department of Clinical Pharmacology, Medical University of Vienna, Department of Clinical Pharmacology, Medical University of Vienna
Malignant childhood central nervous system tumors Maligne ZNS-Tumoren des Kindes- und Jugendalters, Malignant childhood central nervous system tumors Maligne ZNS-Tumoren des Kindes- und Jugendalters, Diseases [C] - Cancer [C04]
 
 
ChiCTR2300070962: Study on the bioequivalence of linezolid tablets (600 mg) in humans

Recruiting
1
48
 
Subjects take one tablet of R medication in the first cycle and one tablet of T medication in the second cycle on an empty stomach ;Subjects take one tablet of T medication in the first cycle and one tablet of R medication in the second cycle on an empty stomach ;After taking a high-fat meal, the subjects took one tablet of T-medication in the first cycle and one tablet of R-medication in the second cycle ;After taking a high-fat meal, the subjects took one tablet of R-medication in the first cycle and one tablet of T-medication in the second cycle
Huzhou Central Hospital, Zhejiang Province; Haikou Pharmaceutical Factory Co., Ltd, Haikou Pharmaceutical Factory Co., Ltd.
Antibacterial
 
 
NCT04545788: Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis

Recruiting
N/A
200
RoW
Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine.
Beijing Chest Hospital
Tuberculosis
12/22
12/22
NCT05813951: Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock

Recruiting
N/A
140
RoW
Linezolid, zyvox
Ain Shams University
Treatment Efficacy
12/23
12/23
ChiCTR2100051699: Efficacy and safety of Diyu Shengbai Tablets in preventing and treating myelosuppression induced by linezolid

Not yet recruiting
N/A
120
 
Oral Diyu Shengbai Pian and linezolid ;Oral linezolid
Infectious Disease Hospital of Heilongjiang; Infectious Disease Hospital of Heilongjiang, Self-financed
Myelosuppression
 
 
ChiCTR2100054786: Early Bactericidal Effect of Contezolid Against Tuberculosis

Not yet recruiting
N/A
20
 
Take linezolid tablets 600 mg orally once daily ;Take contizolid tablets 800 mg twice daily.
Beijing Chest Hospital Affiliated to Capital Medical University; Beijing Chest Hospital Affiliated to Capital Medical University, Capital health development scientific research project
Tuberculosis
 
 
Efficacy and safety of contezolamide tablets in the treatment of pulmonary infection by nontuberculoaus mycobacteria, ChiCTR2300071961: A randomized, open, parallel controlled clinical study of the safety and efficacy of a treatment regimen containing Contezolid tablets in pulmonary infected adult patients by nontuberculoaus mycobacteria

Not yet recruiting
N/A
40
 
Contizolamide was given on the basis of the basic treatment regimen; Linezolid tablets were given on the basis of the basic treatment regimen
Shanghai Pulmonary Hospital; Shanghai Pulmonary Hospital, enterprise support
Pulmonary infection of Mycobacterium abscess
 
 

Download Options